Filing Flows › CVS Health (CVS) › Capital expenditures
CVS Health (CVS) capital expenditures by quarter
CVS Health's capital expenditures were $817M in Q3 2026 (third quarter 2026), +18% from Q2 2026. Over the last 7 quarters it ranged from $607M (Q2 2025) to $849M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $817M | +18% | +17% |
| Q2 2026 | $691M | -19% | +14% |
| Q1 2026 | $849M | +8% | +14% |
| Q4 2025 | $784M | +12% | — |
| Q3 2025 | $698M | +15% | — |
| Q2 2025 | $607M | -18% | — |
| Q1 2025 | $743M | — | — |
Q3 2026 at a glance
CVS Health, Q3 2026: revenue $108.4B (+5% year over year), operating margin 3.3%, net earnings $2.2B, operating cash flow $4.7B. The chart follows the revenue to costs, profit and cash.
Questions
What is CVS Health's capital expenditures?
CVS Health's capital expenditures were $817M in Q3 2026 (third quarter 2026), +18% from Q2 2026.
How has CVS Health's capital expenditures changed?
Over the last 7 quarters it ranged from $607M (Q2 2025) to $849M (Q1 2026).